Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Elisabetta Squame"'
Autor:
Costantina Maisto, Anna Morisco, Roberta de Marino, Elisabetta Squame, Valentina Porfidia, Laura D’Ambrosio, Daria Di Martino, Paolo Gaballo, Michela Aurilio, Monica Buonanno, Aureliana Esposito, Marco Raddi, Secondo Lastoria
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-10 (2021)
Abstract Background Prostate-specific membrane antigen is overexpressed in prostate cancer and it is considered a good target for positron emission tomography/computed tomography imaging of primary cancer and recurrent/metastatic disease, as well as
Externí odkaz:
https://doaj.org/article/e2ca2845be5a47a29b01e368124e5f72
Autor:
Costantina Maisto, Michela Aurilio, Anna Morisco, Roberta de Marino, Monica Josefa Buonanno Recchimuzzo, Luciano Carideo, Laura D’Ambrosio, Francesca Di Gennaro, Aureliana Esposito, Paolo Gaballo, Valentina Pirozzi Palmese, Valentina Porfidia, Marco Raddi, Alfredo Rossi, Elisabetta Squame, Secondo Lastoria
Publikováno v:
Molecules, Vol 27, Iss 12, p 3862 (2022)
The aim of this work is to compare [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 PET/CT as imaging agents in patients with prostate cancer (PCa). Comparisons were made by evaluating times and costs of the radiolabeling process, imaging features including pharm
Externí odkaz:
https://doaj.org/article/c437e6b3cd04488c8365d989227a1d91
Autor:
Secondo Lastoria, Daria Di Martino, Roberta de Marino, Elisabetta Squame, Aureliana Esposito, Paolo Gaballo, Anna Morisco, Valentina Porfidia, Marco Raddi, Monica Buonanno, Michela Aurilio, L. D'Ambrosio, Costantina Maisto
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-10 (2021)
EJNMMI Radiopharmacy and Chemistry
EJNMMI Radiopharmacy and Chemistry
Background Prostate-specific membrane antigen is overexpressed in prostate cancer and it is considered a good target for positron emission tomography/computed tomography imaging of primary cancer and recurrent/metastatic disease, as well as for radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::963685f27187f101b9da27e1f78e2a70
https://doaj.org/article/e2ca2845be5a47a29b01e368124e5f72
https://doaj.org/article/e2ca2845be5a47a29b01e368124e5f72
Autor:
Gaetana Capobianco, Raffaele Di Francia, Elisabetta Squame, Anna De Chiara, Secondo Lastoria, Franco de Martinis, Antonio Pinto, Filippo Russo, Gino Svanera
Publikováno v:
Leukemia & Lymphoma. 48:723-730
The present study has explored the possible value of sCA-125 as a prognostic factor in Hodgkin's lymphoma (HL). From August 1992 to June 2005 sCA-125 was measured at presentation and at the end of the treatments in 221 newly diagnosed adult patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c739d95332badbb24ff2ab4bfea5b63
https://doi.org/10.1080/10428190601183710
https://doi.org/10.1080/10428190601183710